Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Cash Flows From Operating Activities:
Net income (loss) available to common shareholders	$ 32,226	$ 72,944
Dividends on preferred stock	1,200	10,800
Plus: Redemption premium on Series A Preferred Stock	75,198	0
Net income from continuing operations	108,624	83,744
Adjustments to reconcile net income to net cash provided by operating activities:
Bad debt expense (recovery)	(66)	53
Depreciation and amortization	61,383	59,034
Deferred income taxes	7,421	(274)
Equity in earnings of unconsolidated entities	(12,470)	(11,136)
Distribution on investment in AVAIL joint venture	6,764	0
Net gain on sale of property, plant and equipment	(397)	(39)
Amortization of debt financing costs	9,359	9,105
Share-based compensation expense	11,244	6,207
Changes in current assets and current liabilities	2,909	38,819
Changes in other long-term assets and long-term liabilities	(9,174)	(4,585)
Net cash provided by operating activities	185,597	180,928
Cash flows from investing activities
Purchase of property, plant and equipment	(85,942)	(66,900)
Proceeds from sale of property, plant and equipment	842	47
Net cash used in investing activities	(85,100)	(66,853)
Cash flows from financing activities:
Proceeds from issuance of common stock	310,237	1,465
Redemption of Preferred Stock	(308,920)	0
Tax payments related to net share settlement of equity awards	(4,977)	(791)
Proceeds from Revolving Credit Facility	271,000	189,000
Payments on Revolving Credit Facility	(261,000)	(274,000)
Payments of debt financing costs	(1,541)	(1,299)
Payments on long term debt and finance lease liabilities	(90,689)	(268)
Payments of dividends	(18,022)	(23,551)
Net cash used in financing activities	(103,912)	(109,444)
Effect of exchange rate changes on cash	550	58
Net increase (decrease) in cash and cash equivalents	(2,865)	4,689
Cash and cash equivalents at beginning of period	4,349	2,820
Cash and cash equivalents at end of period	$ 1,484	$ 7,509